Women diagnosed with breast cancer stage 0, I, II, and III
Prior to CT/ET, receiving only one of both (no combination)
Age 18 years or above
Have no documented or observable psychiatric or neurological disorders that might interfere with study participation (e.g., dementia or psychosis)
Dutch-speaking (be able to understand the informed consent and study-related questionnaires)
Signed informed consent
You may not be if
Concomitant CT and ET treatment
Structural restorative therapies, such as photobiomodulation therapy (PBM) and fractional CO₂ laser treatment, are not permitted during the study period. During the study period, only symptomatic treatment of GSM (e.g., vaginal lubricants or moisturizers) will be allowed
Clareo Health | Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors
